Insider Trading activities at Lineage Cell Therapeutics, Inc. (LCTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lineage Cell Therapeutics, Inc. (LCTX) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lineage Cell Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 876343.

Total stock buying since 2005: $26,417,625.
Total stock sales since 2005: $8,450,899.
Total stock option exercises since 2005: $3,002,265.


36 insiders reported insider trading activities at Lineage Cell Therapeutics, Inc. (LCTX):
Insider trading activities of Cartt Stephen Lahue
Insider trading activities of Farrell Stephen C
Insider trading activities of Segall Judith
Insider trading activities of Howe Jill Ann
Insider trading activities of Seinberg Steven A
Insider trading activities of Waitz Harold D
Insider trading activities of Sternberg Hal
Insider trading activities of Cohen Abraham E
Insider trading activities of Tew William P Phd
Insider trading activities of Amin Dipti
Insider trading activities of Andrews Deborah J
Insider trading activities of Jayasuriya Anula
Insider trading activities of Bradsher Neal C
Insider trading activities of Broadwood Capital Inc
Insider trading activities of Russell Angus C.
Insider trading activities of Schlachet David
Insider trading activities of West Michael D
Insider trading activities of Patton Stephana Eilene
Insider trading activities of Skibsted Russell
Insider trading activities of Samuel George A. Iii
Insider trading activities of Roberts Brandi
Insider trading activities of Berger Franklin M
Insider trading activities of Mulroy Michael H.
Insider trading activities of Kingsley Alfred D
Insider trading activities of Burns Arnold I
Insider trading activities of Garcia Peter S
Insider trading activities of Mohanty Aditya P.
Insider trading activities of Von Eschenbach Andrew C.
Insider trading activities of Peabody Robert
Insider trading activities of Hernandez Alexandra
Insider trading activities of Culley Brian M
Insider trading activities of Hogge Gary S.
Insider trading activities of Bailey Don M
Insider trading activities of Lichtinger Pedro
Insider trading activities of Gregg Valeta A
Insider trading activities of Leavitt Chase C.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Lineage Cell Therapeutics, Inc. (LCTX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 7,894,737 $3,000,000 0 $0 37,325 $0
2024 6,942,425 $3,675,335 0 $0 37,325 $0
2023 10,000 $10,900 0 $0 50,345 $0
2022 983,756 $742,607 0 $0 30,900 $0
2021 0 $0 564,425 $1,391,274 699,148 $1,005,057
2020 0 $0 0 $0 61,800 $67,901
2019 44,553 $32,271 0 $0 223,600 $0
2018 1,604 $3,769 0 $0 104,687 $0
2017 5,099,925 $6,789,890 150,000 $420,000 37,500 $0
2016 3,032,636 $3,618,000 300,000 $705,000 0 $0
2015 177,000 $598,690 100,000 $383,000 0 $0
2014 4,534,100 $6,128,142 1,000,000 $2,537,980 2,040,400 $1,146,199
2013 838,942 $978,899 533,860 $814,061 0 $0
2012 381,078 $650,774 344,828 $1,000,001 20,000 $14,800
2011 17,400 $76,340 0 $0 129,600 $46,432
2010 0 $0 92,830 $515,554 230,702 $320,471
2009 638,096 $0 216,832 $643,925 243,332 $401,405
2007 0 $0 267,365 $40,104 0 $0
2006 351,315 $87,208 0 $0 0 $0
2005 60,000 $24,800 0 $0 0 $0

Table 2. Monthly summary of insider trading at Lineage Cell Therapeutics, Inc. (LCTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-02 0 $0 0 $0 37,325 $0
2025-01 7,894,737 $3,000,000 0 $0 0 $0
2024-11 95,000 $55,489 0 $0 0 $0
2024-08 10,500 $9,345 0 $0 0 $0
2024-05 10,000 $10,500 0 $0 0 $0
2024-02 6,826,925 $3,600,001 0 $0 37,325 $0
2023-12 10,000 $10,900 0 $0 0 $0
2023-02 0 $0 0 $0 50,345 $0
2022-06 0 $0 0 $0 15,450 $0
2022-03 983,756 $742,607 0 $0 15,450 $0
2021-12 0 $0 539,283 $1,321,808 526,288 $665,486
2021-09 0 $0 0 $0 15,450 $0
2021-06 0 $0 19,142 $56,086 135,960 $299,112
2021-03 0 $0 6,000 $13,380 21,450 $40,459
2020-12 0 $0 0 $0 15,450 $27,192
2020-09 0 $0 0 $0 15,450 $14,476
2020-06 0 $0 0 $0 15,450 $13,441
2020-03 0 $0 0 $0 15,450 $12,792
2019-12 0 $0 0 $0 46,350 $0
2019-09 0 $0 0 $0 77,250 $0
2019-08 44,553 $32,271 0 $0 0 $0
2019-01 0 $0 0 $0 100,000 $0
2018-12 0 $0 0 $0 50,000 $0
2018-10 0 $0 0 $0 25,000 $0

Table 3. Detailed insider trading at Lineage Cell Therapeutics, Inc. (LCTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-02-11 Samuel George A. Iii (General Counsel) Option Ex 6,076 .00 0
2025-02-11 Culley Brian M (President and CEO) Option Ex 31,249 .00 0
2025-01-27 Bradsher Neal C Buy 7,894,737 .38 3,000,000
2024-11-26 Howe Jill Ann (Chief Financial Officer) Buy 15,000 .59 8,850
2024-11-22 Mulroy Michael H. Buy 40,000 .57 22,639
2024-11-21 Culley Brian M (President and CEO) Buy 40,000 .60 24,000
2024-08-16 Howe Jill Ann (Chief Financial Officer) Buy 10,500 .89 9,345
2024-05-24 Culley Brian M (President and CEO) Buy 10,000 1.05 10,500
2024-02-11 Samuel George A. Iii (General Counsel/Secretary) Option Ex 6,076 .00 0
2024-02-11 Culley Brian M (President and CEO) Option Ex 31,249 .00 0
2024-02-08 Bailey Don M Buy 96,155 1.04 100,001
2024-02-06 Bradsher Neal C Buy 6,730,770 .52 3,500,000
2023-12-29 Jayasuriya Anula Buy 10,000 1.09 10,900
2023-02-11 Samuel George A. Iii (General Counsel/Secretary) Option Ex 6,076 .00 0
2023-02-11 Hogge Gary S. (SVP,Clinical & Medical Affairs) Option Ex 13,020 .00 0
2023-02-11 Culley Brian M (President and CEO) Option Ex 31,249 .00 0
2022-06-30 Culley Brian M (President and CEO) Option Ex 15,450 .00 0
2022-03-31 Culley Brian M (President and CEO) Buy 6,400 1.53 9,792
2022-03-31 Culley Brian M (President and CEO) Option Ex 15,450 .00 0
2022-03-28 Amin Dipti Buy 35,000 1.63 57,049
2022-03-25 Culley Brian M (President and CEO) Buy 5,250 1.38 7,244
2022-03-25 Bradsher Neal C Buy 470,000 .72 338,870
2022-03-24 Mulroy Michael H. Buy 7,000 1.40 9,800
2022-03-24 Bradsher Neal C Buy 200,000 .71 142,200
2022-03-23 Bradsher Neal C Buy 260,106 .68 177,652
2021-12-31 Culley Brian M (President and CEO) Option Ex 15,450 .00 0
2021-12-29 Hogge Gary S. (SVP,Clinical & Medical Affairs) Sale 37,695 2.46 92,918
2021-12-29 Hogge Gary S. (SVP,Clinical & Medical Affairs) Option Ex 9,250 .69 6,400
2021-12-28 Hogge Gary S. (SVP,Clinical & Medical Affairs) Sale 501,588 2.45 1,228,890
2021-12-28 Hogge Gary S. (SVP,Clinical & Medical Affairs) Option Ex 501,588 1.31 659,086
2021-09-30 Culley Brian M (President and CEO) Option Ex 15,450 .00 0
2021-06-29 Andrews Deborah J Sale 19,142 2.93 56,086
2021-06-29 Andrews Deborah J Option Ex 24,720 2.20 54,384
2021-06-25 Bradsher Neal C Option Ex 24,720 2.20 54,384
2021-06-22 Kingsley Alfred D Option Ex 61,800 2.20 135,960
2021-06-18 Mulroy Michael H. Option Ex 24,720 2.20 54,384
2021-03-31 Culley Brian M (President and CEO) Option Ex 15,450 2.35 36,307
2021-03-30 Hernandez Alexandra (Sr Director Finance/Controller) Sale 6,000 2.23 13,380
2021-03-30 Hernandez Alexandra (Sr Director Finance/Controller) Option Ex 6,000 .69 4,152
2020-12-31 Culley Brian M (President and CEO) Option Ex 15,450 1.76 27,192
2020-09-30 Culley Brian M (President and CEO) Option Ex 15,450 .94 14,476
2020-06-30 Culley Brian M (President and CEO) Option Ex 15,450 .87 13,441
2020-03-31 Culley Brian M (President and CEO) Option Ex 15,450 .83 12,792
2019-12-31 Culley Brian M (President and CEO) Option Ex 30,900 .00 0
2019-09-30 Culley Brian M (President and CEO) Option Ex 15,450 .00 0
2019-09-17 Culley Brian M (President and CEO) Option Ex 61,800 .00 0
2019-08-15 Bradsher Neal C Buy 13,146 .48 6,362
2019-08-14 Bradsher Neal C Buy 1,407 .49 689
2019-08-13 Leavitt Chase C. (General Counsel/Secretary) Buy 5,000 1.02 5,100
2019-08-13 Roberts Brandi (CFO & SVP, Finance) Buy 5,000 1.01 5,050
2019-08-13 Culley Brian M (President and CEO) Buy 10,000 1.01 10,100
2019-08-13 Bradsher Neal C Buy 10,000 .50 4,970
2019-01-01 Culley Brian M (President and CEO) Option Ex 100,000 .00 0
2018-12-18 Patton Stephana Eilene (General Counsel & Secretary) Option Ex 27,500 .00 0
2018-12-18 Skibsted Russell (Chief Financial Officer) Option Ex 22,500 .00 0
2018-10-04 Patton Stephana Eilene (General Counsel & Secretary) Option Ex 13,750 .00 0
2018-10-04 Skibsted Russell (Chief Financial Officer) Option Ex 11,250 .00 0
2018-09-17 West Michael D (Co-Chief Executive Officer) Option Ex 10,938 .00 0
2018-09-11 Andrews Deborah J (Director) Buy 1,604 2.35 3,769
2018-07-10 Mohanty Aditya P. (Co-Chief Executive Officer) Option Ex 4,687 .00 0
2018-07-10 West Michael D (Co-Chief Executive Officer) Option Ex 1,562 .00 0
2018-04-10 Mohanty Aditya P. (Co-Chief Executive Officer) Option Ex 4,688 .00 0
2018-04-10 West Michael D (Co-Chief Executive Officer) Option Ex 1,563 .00 0
2018-01-10 Mohanty Aditya P. (Co-Chief Executive Officer) Option Ex 4,687 .00 0
2018-01-10 West Michael D (Co-Chief Executive Officer) Option Ex 1,562 .00 0
2017-10-13 Bradsher Neal C Buy 2,692,307 1.30 3,499,999
2017-10-10 Mohanty Aditya P. (Co-Chief Executive Officer) Option Ex 4,688 .00 0
2017-10-10 West Michael D (Co-Chief Executive Officer) Option Ex 1,563 .00 0
2017-08-23 Skibsted Russell (Chief Financial Officer) Buy 2,000 2.64 5,284
2017-08-22 Broadwood Capital Inc Buy 10,000 1.30 12,980
2017-08-22 West Michael D (Co-Chief Executive Officer) Buy 2,000 2.60 5,198
2017-08-21 Patton Stephana Eilene (General Counsel) Buy 7,500 2.58 19,380
2017-08-21 Mohanty Aditya P. (Co-Chief Executive Officer) Buy 7,500 2.50 18,750
2017-08-21 Andrews Deborah J (Director) Buy 2,396 2.50 5,990
2017-07-31 Bradsher Neal C Buy 150,000 1.40 210,000
2017-07-31 Kingsley Alfred D (See Remarks) Sale 150,000 2.80 420,000
2017-07-10 Mohanty Aditya P. (Co-Chief Executive Officer) Option Ex 4,687 .00 0
2017-07-10 West Michael D (Co-Chief Executive Officer) Option Ex 1,562 .00 0
2017-06-16 Andrews Deborah J (Director) Buy 2,000 2.95 5,900
2017-05-16 Andrews Deborah J (Director) Buy 2,000 3.21 6,410
2017-04-10 Mohanty Aditya P. (Co-Chief Executive Officer) Option Ex 18,750 .00 0
2017-04-10 West Michael D (Co-Chief Executive Officer) Option Ex 6,250 .00 0
2017-02-15 Bradsher Neal C Buy 2,222,222 1.35 2,999,999
2016-06-21 Bradsher Neal C Buy 2,732,636 1.20 3,265,500
2016-01-20 Bradsher Neal C Buy 300,000 1.18 352,500
2016-01-20 Kingsley Alfred D (See Remarks) Sale 300,000 2.35 705,000
2015-11-06 Russell Angus C. (Director) Buy 50,000 3.83 191,500
2015-11-06 Kingsley Alfred D (See Remarks) Sale 100,000 3.83 383,000
2015-11-06 Farrell Stephen C (Director) Buy 50,000 3.83 191,500
2015-08-26 Andrews Deborah J (Director) Buy 2,000 2.82 5,640
2015-08-18 Cartt Stephen Lahue (Director) Buy 17,200 2.90 49,828
2015-08-17 Cartt Stephen Lahue (Director) Buy 39,400 2.83 111,462
2015-08-14 Cartt Stephen Lahue (Director) Buy 18,400 2.65 48,760
2014-10-08 Schlachet David (Director) Buy 32,050 3.12 99,996
2014-10-08 Farrell Stephen C (Director) Buy 32,050 3.12 99,996
2014-07-22 Peabody Robert (Sr. VP, COO, and CFO) Sale 100,000 2.65 265,000
2014-07-22 Bradsher Neal C Buy 370,000 1.32 490,250
2014-07-22 West Michael D (Chief Executive Officer) Sale 270,000 2.65 715,500
2014-07-21 Peabody Robert (Sr. VP, COO, and CFO) Option Ex 475,000 .50 237,500
2014-07-21 West Michael D (Chief Executive Officer) Option Ex 1,470,400 .50 735,200
2014-06-30 Bradsher Neal C Option Ex 20,000 2.30 46,000
2014-06-27 Kingsley Alfred D (See Remarks) Option Ex 50,000 2.30 114,999
2014-06-17 Tew William P Phd (Chief Commercial Officer) Sale 7,000 3.23 22,610
2014-06-16 Bradsher Neal C Buy 1,000,000 1.25 1,250,000
2014-06-16 Tew William P Phd (Chief Commercial Officer) Sale 20,000 3.02 60,400
2014-06-13 Tew William P Phd (Chief Commercial Officer) Sale 3,000 2.99 8,970
2014-05-16 Bradsher Neal C Buy 300,000 1.23 367,500
2014-05-16 Kingsley Alfred D (See Remarks) Sale 300,000 2.45 735,000
2014-05-08 Bradsher Neal C Buy 300,000 1.22 365,400
2014-05-08 Kingsley Alfred D (See Remarks) Sale 300,000 2.44 730,500
2014-05-01 Bradsher Neal C Buy 2,000,000 1.26 2,520,000
2014-02-25 Bradsher Neal C Buy 500,000 1.87 935,000
2014-01-06 Peabody Robert (Sr. VP, COO, and CFO) Option Ex 25,000 .50 12,500
2013-12-30 Broadwood Capital Inc Buy 175,000 1.75 305,375
2013-12-27 Broadwood Capital Inc Buy 56,000 1.76 98,840
2013-12-26 Broadwood Capital Inc Buy 69,042 1.76 121,859
2013-11-20 Tew William P Phd (Chief Commercial Officer) Sale 3,860 3.73 14,401
2013-11-18 Tew William P Phd (Chief Commercial Officer) Sale 10,000 3.77 37,660
2013-09-12 Farrell Stephen C (Director) Buy 2,922 3.86 11,275
2013-09-11 Farrell Stephen C (Director) Buy 8,291 3.90 32,326
2013-08-20 Berger Franklin M (Director) Buy 500 3.71 1,854
2013-08-20 Farrell Stephen C (Director) Buy 2,700 3.66 9,879
2013-08-19 Farrell Stephen C (Director) Buy 1,487 3.65 5,421
2013-08-12 Von Eschenbach Andrew C. (Director) Buy 3,000 3.69 11,070
2013-06-04 Lichtinger Pedro (Director) Buy 120,000 .00 0
2013-06-04 Bradsher Neal C Buy 200,000 .00 0
2013-06-04 Kingsley Alfred D (See Remarks) Sale 320,000 .00 0
2013-03-28 Bradsher Neal C Buy 200,000 1.91 381,000
2013-03-28 Kingsley Alfred D (See Remarks) Sale 200,000 3.81 762,000
2012-11-15 Bradsher Neal C Buy 344,828 1.45 500,000
2012-11-15 Kingsley Alfred D (See Remarks) Sale 344,828 2.90 1,000,001
2012-05-31 West Michael D (Chief Executive Officer) Buy 10,000 4.05 40,490
2012-04-24 West Michael D (Chief Executive Officer) Option Ex 20,000 .74 14,800
2012-04-12 Burns Arnold I (Director) Buy 5,000 4.17 20,850
2012-04-11 Lichtinger Pedro (Director) Buy 6,250 3.98 24,850
2012-04-11 Cohen Abraham E (Director) Buy 10,000 4.12 41,200
2012-03-19 Garcia Peter S (Chief Financial Officer) Buy 5,000 4.68 23,384
2011-11-29 Garcia Peter S (Chief Financial Officer) Buy 2,000 4.17 8,340
2011-11-22 Segall Judith (Vice President & Secretary) Option Ex 80,000 .32 25,600
2011-06-22 Peabody Robert (Senior VP, COO & CFO) Buy 5,400 4.45 24,040
2011-06-22 West Michael D (Chief Executive Officer) Buy 10,000 4.40 43,960
2011-01-03 West Michael D (Chief Executive Officer) Option Ex 49,600 .42 20,832
2010-11-23 Segall Judith (Vice President & Secretary) Sale 2,128 7.70 16,381
2010-11-22 Segall Judith (Vice President & Secretary) Sale 17,400 7.52 130,882
2010-11-19 Segall Judith (Vice President & Secretary) Sale 7,600 7.47 56,794
2010-11-05 Segall Judith (Vice President & Secretary) Option Ex 125,000 2.00 250,000
2010-09-03 Seinberg Steven A (Chief Financial Officer) Sale 10,000 4.44 44,429
2010-09-02 Seinberg Steven A (Chief Financial Officer) Sale 40,000 4.47 178,840
2010-09-01 Seinberg Steven A (Chief Financial Officer) Sale 10,000 4.39 43,890
2010-08-19 Seinberg Steven A (Chief Financial Officer) Option Ex 80,000 .32 25,600
2010-05-12 Gregg Valeta A (Director) Sale 5,702 7.78 44,338
2010-05-12 Gregg Valeta A (Director) Option Ex 5,702 3.45 19,671
2010-03-19 West Michael D (Chief Executive Officer) Option Ex 20,000 1.26 25,200
2009-09-23 Gregg Valeta A (Director) Sale 10,000 6.01 60,119
2009-09-23 Gregg Valeta A (Director) Option Ex 10,000 .44 4,400
2009-09-21 Gregg Valeta A (Director) Sale 10,000 5.59 55,940
2009-09-21 Gregg Valeta A (Director) Option Ex 10,000 .74 7,400
2009-09-16 Gregg Valeta A (Director) Sale 4,500 4.04 18,171
2009-09-16 Gregg Valeta A (Director) Option Ex 4,500 .74 3,330
2009-09-15 Gregg Valeta A (Director) Sale 5,500 4.01 22,055
2009-09-15 Gregg Valeta A (Director) Option Ex 5,500 .74 4,070
2009-08-20 Bradsher Neal C (Director) Buy 638,096 .00 0
2009-07-27 Gregg Valeta A (Director) Sale 5,000 3.51 17,550
2009-07-27 Gregg Valeta A (Director) Option Ex 5,000 .34 1,700
2009-07-08 Gregg Valeta A (Director) Sale 1,000 2.50 2,500
2009-07-08 Gregg Valeta A (Director) Option Ex 1,000 .34 340
2009-07-01 Gregg Valeta A (Director) Sale 32,332 2.38 77,111
2009-07-01 Gregg Valeta A (Director) Option Ex 32,332 .93 30,165
2009-05-29 Seinberg Steven A (CFO) Option Ex 2,500 2.00 5,000
2009-05-29 Segall Judith (Vice President & Secretary) Option Ex 5,000 2.00 10,000
2009-05-29 Waitz Harold D (Vice President) Sale 2,000 2.72 5,434
2009-05-29 Waitz Harold D (Vice President) Option Ex 16,000 2.00 32,000
2009-05-29 Sternberg Hal (Vice President) Option Ex 5,000 2.00 10,000
2009-05-28 Seinberg Steven A (CFO) Sale 22,500 2.54 57,217
2009-05-28 Seinberg Steven A (CFO) Option Ex 22,500 2.00 45,000
2009-05-28 Segall Judith (Vice President & Secretary) Sale 45,000 2.46 110,610
2009-05-28 Segall Judith (Vice President & Secretary) Option Ex 45,000 2.00 90,000
2009-05-28 Waitz Harold D (Vice President) Sale 34,000 2.85 96,798
2009-05-28 Waitz Harold D (Vice President) Option Ex 34,000 2.00 68,000
2009-05-28 Sternberg Hal (Vice President) Sale 45,000 2.68 120,420
2009-05-28 Sternberg Hal (Vice President) Option Ex 45,000 2.00 90,000
2007-12-21 Bradsher Neal C (10% Owner) Sale 267,365 .15 40,104
2006-08-22 Kingsley Alfred D (Other) Buy 89,512 .20 17,902
2006-06-26 Kingsley Alfred D (Other) Buy 51,536 .24 12,368
2006-06-23 Kingsley Alfred D (Other) Buy 1,150 .24 276
2006-06-22 Kingsley Alfred D (Other) Buy 72 .24 17
2006-06-20 Kingsley Alfred D (Other) Buy 45 .24 10
2006-06-07 Kingsley Alfred D (Other) Buy 34,000 .24 8,160
2006-05-05 Kingsley Alfred D (Other) Buy 175,000 .28 48,475
2005-07-20 Kingsley Alfred D (Other) Buy 20,000 .42 8,400
2005-07-14 Kingsley Alfred D (Other) Buy 40,000 .41 16,400

Insider trading activities including stock purchases, stock sales, and option exercises of LCTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lineage Cell Therapeutics, Inc. (symbol LCTX, CIK number 876343) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.